Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London
SEC filing record 1 source field available
Fiscal year end
31 December
Mereo BioPharma Group plc has filed 433 SEC EDGAR filings since 01 Dec 2017

SEC filing history

Showing 201-225 of 433 matching filings.

Per page
25
Current page
9
6-K File 001-38452

6-K

Filing date
06 Jul 2023
Reporting date
06 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
30 Jun 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91444

SC 13D/A

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
07 Jun 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
05 Jun 2023
Reporting date
05 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
22 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
08 May 2023
Reporting date
08 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
05 May 2023
Reporting date
05 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
12 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
28 Mar 2023
Reporting date
28 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
21 Mar 2023
Reporting date
21 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

AMENDMENT NO. 2

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SCHEDULE 13G (AMENDMENT NO. 2)

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91444

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-269388

S-8

Filing date
24 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38452

6-K

Filing date
02 Nov 2022
Reporting date
02 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91444

AMENDMENT NO. 5

Filing date
28 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .